Armephaco JSC

Armephaco JSC Operating Cash Flow

The Operating Cash Flow of Armephaco JSC (AMP.VN) as of Nov 15, 2026 is -36.99 B VND. In the previous year, Operating Cash Flow was 19.50 B VND — a change of -289.65% (lower).

Operating Cash Flow

-36.99 BVND

YoY

-289.65%

Last updated:

Operating Cash Flow of Armephaco JSC is 2024 -36.99 B VND. Operating Cash Flow of Armephaco JSC was 2023 19.50 B VND. It decreases by -289.65% lower compared to the previous year.

The Armephaco JSC Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2017
136.00 M VND
Jan 1, 2018
-12.36 B VND
Jan 1, 2019
3.50 B VND
Jan 1, 2020
-11.57 B VND
Jan 1, 2021
69.06 B VND
Jan 1, 2022
10.82 B VND
Jan 1, 2023
19.50 B VND
Jan 1, 2024
-36.99 B VND
The Armephaco JSC Operating Cash Flow history
YEAROperating Cash FlowYoY
-36.99 BVND-289.65%
19.50 BVND+80.31%
10.82 BVND-84.34%
69.06 BVND-697.05%
-11.57 BVND-430.27%
3.50 BVND-128.34%
-12.36 BVND-9,184.56%
136.00 MVND-100.09%
-152.20 BVND-126,930.00%
120.00 MVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC manufactures pharmaceutical and medical equipment products, focusing on glucose meters, sphygmomanometers, beds, medical exam tables, stools, and syringe destroyers. The company distributes medical devices and equipment through its manufacturing and distribution channels, targeting healthcare providers and hospitals. It also produces and trades diversified medicines, including antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal, and anti-allergic drugs, serving the broader healthcare market. The firm generates revenue from the sale of medical devices and equipment, as well as from pharmaceutical products. Healthcare providers and hospitals purchase the medical devices and equipment, while the diversified medicines are sold to pharmacies and healthcare institutions. Armephaco JSC's product portfolio includes glucose meters, sphygmomanometers, beds, medical exam tables, stools, syringe destroyers, antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal, and anti-allergic drugs. Armephaco JSC's business model centers on the production and distribution of medical devices and pharmaceuticals. The company's primary customers are healthcare providers, hospitals, pharmacies, and healthcare institutions. The revenue streams are derived from the direct sale of medical equipment and pharmaceutical products to these segments, with no mention of additional services or partnerships. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

Operating Cash Flow of Armephaco JSC is -36.99 B VND in 2024.

Operating Cash Flow of Armephaco JSC changed from 19.50 B VND to -36.99 B VND, representing a -289.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Armephaco JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Armephaco JSC

All Key Metrics — Armephaco JSC